- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- April 2023
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- February 2022
- 92 Pages
Global
From €3200EUR$3,566USD£2,840GBP
- Report
- October 2023
- 90 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- December 2022
- 234 Pages
Global
From €5507EUR$5,730USD£4,723GBP
- Report
- May 2023
- 147 Pages
Global
From €5766EUR$5,999USD£4,945GBP
The Electroconvulsive Therapy Device (ECT) market is a segment of the medical device industry that focuses on the use of electrical stimulation to treat mental health disorders. ECT devices are used to induce seizures in patients with severe depression, bipolar disorder, and other mental health conditions. The device consists of a generator, electrodes, and a patient interface. The generator produces a brief electrical current that is delivered to the patient through the electrodes. The patient interface is used to monitor the patient's vital signs during the procedure.
ECT devices are used in both inpatient and outpatient settings. The devices are typically used in combination with other treatments such as psychotherapy and medication. The market for ECT devices is expected to grow in the coming years due to the increasing prevalence of mental health disorders.
Some companies in the ECT device market include Neurosoft, Mecta, Magstim, and Somatics. Show Less Read more